PetMed Express, Inc. (PETS) CEO Sells $1,530,000.00 in Stock

PetMed Express, Inc. (NASDAQ:PETS) CEO Menderes Akdag sold 30,000 shares of the firm’s stock in a transaction that occurred on Thursday, January 11th. The stock was sold at an average price of $51.00, for a total transaction of $1,530,000.00. Following the transaction, the chief executive officer now directly owns 490,000 shares in the company, valued at $24,990,000. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website.

PetMed Express, Inc. (NASDAQ PETS) opened at $52.94 on Tuesday. PetMed Express, Inc. has a one year low of $19.21 and a one year high of $53.32. The stock has a market cap of $1,090.79, a P/E ratio of 35.53, a PEG ratio of 3.14 and a beta of 1.12.

PetMed Express (NASDAQ:PETS) last released its quarterly earnings data on Monday, October 23rd. The company reported $0.43 earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of $0.30 by $0.13. PetMed Express had a net margin of 11.58% and a return on equity of 31.46%. The firm had revenue of $66.70 million for the quarter, compared to the consensus estimate of $63.41 million. During the same period last year, the firm earned $0.24 earnings per share. The company’s quarterly revenue was up 9.7% on a year-over-year basis. equities analysts expect that PetMed Express, Inc. will post 1.68 EPS for the current fiscal year.

PETS has been the topic of a number of recent research reports. Zacks Investment Research downgraded shares of PetMed Express from a “strong-buy” rating to a “hold” rating in a research note on Monday, September 25th. BidaskClub upgraded shares of PetMed Express from a “buy” rating to a “strong-buy” rating in a research note on Saturday, December 9th. Northcoast Research set a $58.00 price objective on shares of PetMed Express and gave the company a “buy” rating in a research note on Wednesday, January 3rd. ValuEngine downgraded shares of PetMed Express from a “buy” rating to a “hold” rating in a research note on Monday, October 2nd. Finally, Noble Financial reiterated a “hold” rating on shares of PetMed Express in a research note on Friday, October 27th. One research analyst has rated the stock with a sell rating, four have issued a hold rating, two have issued a buy rating and one has assigned a strong buy rating to the company’s stock. The company currently has an average rating of “Hold” and an average target price of $42.80.

A number of institutional investors and hedge funds have recently made changes to their positions in PETS. Acrospire Investment Management LLC acquired a new stake in PetMed Express in the second quarter valued at approximately $110,000. Pinebridge Investments L.P. boosted its stake in PetMed Express by 1.0% in the second quarter. Pinebridge Investments L.P. now owns 2,704 shares of the company’s stock valued at $110,000 after acquiring an additional 27 shares in the last quarter. Sei Investments Co. boosted its stake in PetMed Express by 50,142.9% in the third quarter. Sei Investments Co. now owns 3,517 shares of the company’s stock valued at $117,000 after acquiring an additional 3,510 shares in the last quarter. Thompson Siegel & Walmsley LLC acquired a new stake in PetMed Express in the third quarter valued at approximately $149,000. Finally, Fred Alger Management Inc. acquired a new stake in PetMed Express in the second quarter valued at approximately $162,000. Institutional investors own 99.88% of the company’s stock.

TRADEMARK VIOLATION WARNING: This article was posted by American Banking News and is the sole property of of American Banking News. If you are accessing this article on another domain, it was copied illegally and reposted in violation of U.S. & international copyright and trademark legislation. The legal version of this article can be viewed at https://www.americanbankingnews.com/2018/01/16/petmed-express-inc-pets-ceo-sells-1530000-00-in-stock.html.

About PetMed Express

PetMed Express, Inc (PetMed Express), doing business as 1800PetMeds, is a pet pharmacy. The Company markets prescription and non-prescription pet medications, and other health products for dogs and cats, direct to the consumer. It offers a selection of products for dogs and cats. Its product line contains approximately 3,000 stock keeping units (SKUS) of pet medications, health products and supplies.

Insider Buying and Selling by Quarter for PetMed Express (NASDAQ:PETS)

Receive News & Ratings for PetMed Express Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for PetMed Express and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply